JP5309207B2 - 二重壁ステントシステム - Google Patents
二重壁ステントシステム Download PDFInfo
- Publication number
- JP5309207B2 JP5309207B2 JP2011503025A JP2011503025A JP5309207B2 JP 5309207 B2 JP5309207 B2 JP 5309207B2 JP 2011503025 A JP2011503025 A JP 2011503025A JP 2011503025 A JP2011503025 A JP 2011503025A JP 5309207 B2 JP5309207 B2 JP 5309207B2
- Authority
- JP
- Japan
- Prior art keywords
- stent
- stent element
- longitudinally extending
- strut
- proximal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000463 material Substances 0.000 claims description 33
- 238000004904 shortening Methods 0.000 claims description 11
- ORQBXQOJMQIAOY-UHFFFAOYSA-N nobelium Chemical compound [No] ORQBXQOJMQIAOY-UHFFFAOYSA-N 0.000 description 26
- 238000003466 welding Methods 0.000 description 22
- 230000017531 blood circulation Effects 0.000 description 20
- 229910001000 nickel titanium Inorganic materials 0.000 description 18
- 238000007667 floating Methods 0.000 description 17
- 210000004204 blood vessel Anatomy 0.000 description 13
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 9
- 239000002184 metal Substances 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 230000005856 abnormality Effects 0.000 description 7
- 150000002739 metals Chemical class 0.000 description 7
- 210000003102 pulmonary valve Anatomy 0.000 description 7
- 230000002861 ventricular Effects 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 6
- 239000004744 fabric Substances 0.000 description 6
- 230000005012 migration Effects 0.000 description 6
- 238000013508 migration Methods 0.000 description 6
- 238000005476 soldering Methods 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- 229910045601 alloy Inorganic materials 0.000 description 5
- 239000000956 alloy Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 230000008467 tissue growth Effects 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000003698 laser cutting Methods 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 0 CCC(C)C(C)C(C*C*C=CCC(C)CC1)*(C2)=C(C)CCC2C1C1**CCCCCCC*(C)(CC(C2)(C(C)CC)C2C2CC2)**(C)*=CC1 Chemical compound CCC(C)C(C)C(C*C*C=CCC(C)CC1)*(C2)=C(C)CCC2C1C1**CCCCCCC*(C)(CC(C2)(C(C)CC)C2C2CC2)**(C)*=CC1 0.000 description 3
- 206010007559 Cardiac failure congestive Diseases 0.000 description 3
- 241000219109 Citrullus Species 0.000 description 3
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 3
- 229920004934 Dacron® Polymers 0.000 description 3
- 206010019280 Heart failures Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- -1 but not limited to Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 210000003709 heart valve Anatomy 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000000116 mitigating effect Effects 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 208000009138 pulmonary valve stenosis Diseases 0.000 description 3
- 229910000679 solder Inorganic materials 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 2
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 239000010952 cobalt-chrome Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000010297 mechanical methods and process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 206010002329 Aneurysm Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 229910000531 Co alloy Inorganic materials 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 208000035211 Heart Murmurs Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 229910001257 Nb alloy Inorganic materials 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 229910001260 Pt alloy Inorganic materials 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 210000001765 aortic valve Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 229910001566 austenite Inorganic materials 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000009546 growth abnormality Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 238000010329 laser etching Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 229910000734 martensite Inorganic materials 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 210000000591 tricuspid valve Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000006496 vascular abnormality Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/060,332 US7815673B2 (en) | 2008-04-01 | 2008-04-01 | Double-walled stent system |
| US12/060,332 | 2008-04-01 | ||
| PCT/US2009/037539 WO2009123859A1 (en) | 2008-04-01 | 2009-03-18 | Double-walled stent system |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011516158A JP2011516158A (ja) | 2011-05-26 |
| JP2011516158A5 JP2011516158A5 (enExample) | 2012-05-10 |
| JP5309207B2 true JP5309207B2 (ja) | 2013-10-09 |
Family
ID=44193849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011503025A Expired - Fee Related JP5309207B2 (ja) | 2008-04-01 | 2009-03-18 | 二重壁ステントシステム |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5309207B2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013152327A1 (en) * | 2012-04-06 | 2013-10-10 | Merlin Md Pte Ltd. | Devices and methods for treating an aneurysm |
| JP2015070978A (ja) * | 2013-10-04 | 2015-04-16 | ソルブ株式会社 | ステント |
| CN116390697A (zh) * | 2020-11-18 | 2023-07-04 | 微仙美国有限公司 | 梭状动脉瘤治疗 |
| CN115814260B (zh) * | 2022-12-28 | 2023-12-29 | 心擎医疗(苏州)股份有限公司 | 一种具有辅助导流的导管泵 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050075725A1 (en) * | 2003-10-02 | 2005-04-07 | Rowe Stanton J. | Implantable prosthetic valve with non-laminar flow |
| WO2005096993A1 (en) * | 2004-03-31 | 2005-10-20 | Med Institute, Inc. | Endoluminal graft with a prosthetic valve |
-
2009
- 2009-03-18 JP JP2011503025A patent/JP5309207B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011516158A (ja) | 2011-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2285318B1 (en) | Double-walled stent system | |
| JP5491491B2 (ja) | 選択フレア型クラウンを有するステント補綴具 | |
| US8128686B2 (en) | Branched vessel prosthesis | |
| CN107184292B (zh) | 铰接式连合瓣膜支架和方法 | |
| AU2016203206B2 (en) | System and method for assembling a folded percutaneous valve | |
| AU2006251888B2 (en) | Apparatus and methods for repairing the function of a diseased valve and method for making same | |
| US7377938B2 (en) | Prosthetic cardiac value and method for making same | |
| US8123794B2 (en) | Intraluminal support frame | |
| CN103153232B (zh) | 具有低心室型面的二尖瓣假体 | |
| JP5309207B2 (ja) | 二重壁ステントシステム | |
| JP5537540B2 (ja) | 二重壁ステントシステム | |
| US10335272B2 (en) | Apparatus and method for repairing the function of a diseased valve | |
| WO2025199016A1 (en) | Prosthetic valves with anchoring sections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120316 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120316 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130527 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130605 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130701 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5309207 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |